Table 2:
Laboratory parameters and radiological findings of patients on admission
| Variable | Survivor | Non-survivor | Total | P value |
| (n=101) | (n=24) | (n=125) | ||
| WBC Count (*109 per L) | 6.97 (5.56-12.75) | 9.86 (5.64-13.8) | 7.29 (5.58-13.36) | 0.403 |
| <4 | 5 (5.0%) | 1 (4.2%) | 6 (4.8%) | 0.226 |
| 4 to 11 | 68 (67.3%) | 12 (50.0%) | 80 (64.0%) | |
| >11 | 28 (27.7%) | 11 (45.8%) | 39 (31.2%) | |
| Lymphocyte count (109 per L) | 31.5 (23.30-37.50) | 9.05 (6.05-14.75) | 28.0 (15.0-36.0) | <0.001 |
| Neutrophil count (109 per L) | 55.0 (48.05-65.0) | 85.0 (77.50-88.75) | 59.20 (49.0-77.0) | <0.001 |
| Haemoglobin (gm/dl) | 13.60 (12.30-14.85) | 12.15 (11.17-13.45) | 13.50 (11.9-14.6) | 0.002 |
| Platelet count (109 per L) | 221.0 (156.0-258.50) | 226.50 (156.25-299.25) | 221.0 (156.0-261.50) | 0.599 |
| <100 | 7 (6.9%) | 3 (12.5%) | 10 (8.0%) | 0.403 |
| Albumin (gm/dl) | 4.04 (3.71-4.37) | 3.09 (2.78-3.37) | 3.94 (3.3-4.27) | <0.001 |
| SGOT, (U/L) | 24.0 (18.0-34.0) | 37.0 (17.25-54.75) | 25.0 (18.0-38.0) | 0.124 |
| >40 | 17 (16.8%) | 11 (45.8%) | 28 (22.4%) | 0.002 |
| SGPT, (U/L) | 26.0 (19.0-47.0) | 59.5 (36.75-89.75) | 28.0 (20.0-53.0) | <0.001 |
| >40 | 33 (32.7%) | 17 (70.8%) | 50 (40.0%) | 0.001 |
| Creatinine (mg/dl) | 0.96 (0.94-1.07) | 1.17 (0.86-1.56) | 0.97 (0.85-1.13) | 0.029 |
| >1.2 | 7 (6.9%) | 7 (29.2%) | 14 (11.2%) | 0.006 |
| LDH, (U/L) | 210.0 (173.5-244.5) | 546.50 (362.5-645.75) | 223.0 (184.5-345.0) | <0.001 |
| >250 | 24 (23.8%) | 22 (91.7%) | 46 (36.8%) | <0.001 |
| Prothrombin time (secs) | 13.8 (13.09-14.80) | 14.45 (13.62-17.07) | 13.9 (13.2-14.95) | 0.01 |
| <16 | 93 (92.1%) | 16 (66.7%) | 109 (87.2%) | 0.003 |
| INR | 1.04 (0.98-1.12) | 1.07 (1.02-1.33) | 1.05 (0.98-1.14) | 0.008 |
| >1.1 | 30 (29.7%) | 11 (45.8%) | 41 (32.8%) | 0.13 |
| D-dimer (ug/ml) | 0.37 (0.27-0.91) | 3.20 (1.47-8.60) | 0.56 (0.27-1.51) | <0.001 |
| >1 | 24 (23.8%) | 20 (83.3%) | 44 (35.2%) | |
| Ferritin (ng/ml) | 168.4 (58.8-298.07) | 529.0 (299.95-975.25) | 217.30 (83.20-417.50) | <0.001 |
| >300 | 25 (24.8%) | 18 (75.0%) | 43 (34.4%) | <0.001 |
| IL-6 (pg/ml) | 5.52 (2.24-22.27) | 342.6 (48.17-857.2) | 8.25 (2.74-81.45) | <0.001 |
| Pro-calcitonin (ng/ml) | 0.04 (0.02-0.26) | 0.56 (0.14-1.5) | 0.05 (0.02-0.495) | <0.001 |
| 0 to 0.25 | 76 (75.2%) | 8 (33.3%) | 84 (67.2%) | <0.001 |
| 0.25 to 0.5 | 8 (7.9%) | 3 (12.5%) | 11 (8.8%) | |
| >0.5 | 17 (16.8%) | 13 (54.2%) | 30 (24.0%) | |
| Creatinine Kinase (U/L) | 70.0 (46.0-103.0) | 55.5 (29.0-81.0) | 67.0 (42.5-99.0) | 0.075 |
| >185 | 6 (5.9%) | 2 (8.3%) | 8 (6.4%) | <0.001 |
| Radiological | (n=14) | (n=24) | (n=38) | p value |
| Total Severity Score (mean ± SD) | 1.24±3.49 | 12.29±4.19 | 3.36±5.67 | <0.001 |
| Imaging features | ||||
| Consolidation | 9 (64.3%) | 21 (87.5%) | 30 (24.0%) | <0.001 |
| Infiltrates | 5 (35.7%) | 3 (12.5%) | 8 (6.4%) |